{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:35:45Z","timestamp":1770896145594,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jmii.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T08:49:29Z","timestamp":1414831769000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan"],"prefix":"10.1016","volume":"49","author":[{"given":"Chih-Chen","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Len","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.08.006_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.antiviral.2009.10.021","article-title":"Viral hepatitis and HIV co-infection","volume":"85","author":"Soriano","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jmii.2014.08.006_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cis404","article-title":"Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy","volume":"55","author":"Branch","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib3","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jmii.2014.08.006_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jac\/dkl524","article-title":"Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors","volume":"59","author":"Rivero","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.08.006_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2002.30319","article-title":"Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections","volume":"35","author":"Sulkowski","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2014.08.006_bib6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN study","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2014.08.006_bib7","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/381453","article-title":"Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection","volume":"38","author":"Bonacini","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1468-1293.2005.00291.x","article-title":"Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London","volume":"6","author":"Mohsen","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2014.08.006_bib9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib10","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/429491","article-title":"Coinfection with HIV and hepatitis C virus among injection drug users in southern China","volume":"41","author":"Garten","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042560-200202010-00014","article-title":"High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China","volume":"29","author":"Zhang","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2014.08.006_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cld.2007.06.008","article-title":"Drug-induced liver injury associated with HIV medications","volume":"11","author":"Jain","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.26741","article-title":"Fibrosis progression in human immunodeficiency virus\/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs","volume":"59","author":"Konerman","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2014.08.006_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2014.08.006_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2008.11.019","article-title":"Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus","volume":"7","author":"Tural","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2014.08.006_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.2005.065904","article-title":"Prediction of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients by simple non-invasive indexes","volume":"55","author":"Mac\u00edas","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jmii.2014.08.006_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1468-1293.2005.00330.x","article-title":"Validation of a simple model for predicting liver fibrosis in HIV\/hepatitis C virus-coinfected patients","volume":"6","author":"Al-Mohri","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2014.08.006_bib18","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1572-0241.2008.01954.x","article-title":"Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort","volume":"103","author":"Loko","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmii.2014.08.006_bib19","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/jac\/dkr357","article-title":"Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV\/hepatitis C virus co-infected patients","volume":"66","author":"Neukam","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.08.006_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427216","article-title":"Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection","volume":"40","author":"Aranzabal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jinf.2011.10.016","article-title":"Hepatic safety of efavirenz in HIV\/hepatitis C virus-coinfected patients with advanced liver fibrosis","volume":"64","author":"Pineda","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2014.08.006_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/jac\/dkn045","article-title":"Liver toxicity of antiretroviral combinations including atazanavir\/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis","volume":"61","author":"Pineda","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.08.006_bib23","doi-asserted-by":"crossref","first-page":"e94791","DOI":"10.1371\/journal.pone.0094791","article-title":"Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection","volume":"9","author":"Hsieh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2014.08.006_bib24","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jhep.2005.11.027","article-title":"Hepatotoxicity of antiretrovirals: incidence, mechanisms and management","volume":"44","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2014.08.006_bib25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(03)14844-1","article-title":"Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection","volume":"362","author":"Qurishi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2014.08.006_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/jhep.2001.26517","article-title":"Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy","volume":"34","author":"Benhamou","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2014.08.006_bib27","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0168-8278(04)90091-8","article-title":"Control of HIV viral load through highly active antiretroviral therapy (HAART) slows down liver fibrosis progression in HIV\/HCV-coinfection and makes it the same as in HCV-monoinfection. The Puerto Rico-New York hepatitis C study group","volume":"40","author":"Br\u00e4u","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2014.08.006_bib28","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2014.08.006_bib29","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dieterich","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.08.006_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1293.2008.00513.x","article-title":"Risk of side effects associated with the use of nevirapine in treatment-na\u00efve patients, with respect to gender and CD4 cell count","volume":"9","author":"Knobel","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2014.08.006_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1468-1293.2010.00873.x","article-title":"Nevirapine-associated hepatotoxicity was not predicted by CD4 count \u2265250 cells\/\u03bcL among women in Zambia, Thailand and Kenya","volume":"11","author":"Peters","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2014.08.006_bib32","doi-asserted-by":"crossref","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","article-title":"Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection","volume":"5","author":"Grant","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2014.08.006_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jac\/dkl214","article-title":"Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C","volume":"58","author":"Mira","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:34Z","timestamp":1761657634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118214001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1684118214001741"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.08.006","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC","name":"copyright","label":"Copyright"}]}}